Q2 2026 Holdings
Filed 2026-08-13 | 29 holdings | $470.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $81.9M | 1,431,590 | 17.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $43.3M | 343,043 | 9.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $28.6M | 1,089,701 | 6.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $28.2M | 52,545 | 6.0% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $26.5M | 892,621 | 5.6% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $25.3M | 3,655,075 | 5.4% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $25.0M | 1,339,212 | 5.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $23.4M | 677,879 | 5.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $22.2M | 367,900 | 4.7% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $19.4M | 233,808 | 4.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $16.3M | 512,856 | 3.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $16.1M | 894,058 | 3.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $13.0M | 122,375 | 2.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $12.2M | 98,442 | 2.6% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $10.1M | 420,751 | 2.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $9.3M | 1,759,492 | 2.0% |
| Immunic Inc(IMUX) | COM NEW | 4525EP200 | $8.3M | 539,814 | 1.8% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.1M | 747,313 | 1.7% |
| Tonix Pharmaceuticals Hldg C(TNXP) | COM NEW | 890260839 | $8.0M | 625,428 | 1.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.4M | 340,000 | 1.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $7.2M | 574,166 | 1.5% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $6.7M | 659,213 | 1.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $6.1M | 653,572 | 1.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $5.6M | 57,100 | 1.2% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $5.5M | 11,123 | 1.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $2.5M | 49,850 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.2M | 40,567 | 0.5% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $1.8M | 161,486 | 0.4% |
| Achieve Life Science Inc(ACHV) | COM | 004468500 | $174.7K | 26,760 | 0.0% |